Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2810898 | 0.93 | PLA2G4A (0.55) | PLA2G4AMDH1 | |
| SCHEMBL2806139 | 0.85 | PLA2G4A (0.79) | PLA2G4A | |
| SCHEMBL2835991 | 0.84 | PLA2G4A (0.78) | PLA2G4A | |
| SCHEMBL2804337 | 0.84 | PLA2G4A (0.58) | PLA2G4AMDH1 | |
| SCHEMBL2807125 | 0.83 | PLA2G4A (0.57) | PLA2G4AMDH1 | |
| SCHEMBL2808305 | 0.78 | PLA2G4A (0.49) | PLA2G4A | |
| SCHEMBL2806998 | 0.74 | AKR1C3 (0.39) | PLA2G4A | |
| SCHEMBL13127470 | 0.73 | PLA2G4A (1.00) | PLA2G4A | |
| SCHEMBL2810890 | 0.73 | PLA2G4A (0.80) | PLA2G4A | |
| SCHEMBL2810903 | 0.73 | PLA2G4A (0.48) | PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240718-A1 | NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVE, SUITABLE FOR INHIBITING PHOSPHOLIPASE A2 | WESTFALISCHE WILHELMS UNIVERSITÄT MÜNSTER (DE) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240718-A1 | NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVE, SUITABLE FOR INHIBITING PHOSPHOLIPASE A2 | PLD2, PLA2G1B, PLA2G4A | PLA2G4A 3/4885MDH1 2682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.